PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 18.725 USD 0.19% Market Closed
Market Cap: 448.1m USD

Relative Value

The Relative Value of one PRTC stock under the Base Case scenario is 4.636 USD. Compared to the current market price of 18.725 USD, PureTech Health PLC is Overvalued by 75%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRTC Relative Value
Base Case
4.636 USD
Overvaluation 75%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
12
Median 3Y
59.4
Median 5Y
49
Industry
7.5
Forward
1.6
vs History
vs Industry
Median 3Y
-12.8
Median 5Y
-15.7
Industry
21.3
Forward
-0.3
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-6.4
Industry
21.6
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-6
Industry
23.3
vs History
41
vs Industry
56
Median 3Y
1.5
Median 5Y
1.5
Industry
2.5
vs History
vs Industry
Median 3Y
-2 764.5
Median 5Y
-8 984.3
Industry
7.4
Forward
-179.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.8
vs History
3
vs Industry
0
Median 3Y
211.8
Median 5Y
196.4
Industry
4.2
Forward
3.6
vs History
3
vs Industry
0
Median 3Y
204.6
Median 5Y
187.7
Industry
4
Forward
3.5
vs History
3
vs Industry
0
Median 3Y
258.6
Median 5Y
207
Industry
6.1
vs History
3
vs Industry
0
Median 3Y
249.6
Median 5Y
206.2
Industry
3.9
vs History
vs Industry
Median 3Y
-94.5
Median 5Y
-85.5
Industry
4.6

Multiples Across Competitors

PRTC Competitors Multiples
PureTech Health PLC Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
PureTech Health PLC
NASDAQ:PRTC
350.5m USD 934.6 -5.3 362.5 352.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 341 173.5 -182 229.9 -221 285.1 -218 760
US
Abbvie Inc
NYSE:ABBV
317.2B USD 5.7 62.4 15.5 23.9
US
Amgen Inc
NASDAQ:AMGN
140.9B USD 4.3 33.3 16 30.3
US
Gilead Sciences Inc
NASDAQ:GILD
112.9B USD 4 896.2 9.9 9.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD 9.9 -219.3 21.6 22.7
US
Epizyme Inc
F:EPE
94.1B EUR 1 837.4 -468.9 -510.6 -497
AU
CSL Ltd
ASX:CSL
139.4B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD 5.8 17.3 15.7 17.5
US
Seagen Inc
F:SGT
39.3B EUR 17.7 -54.3 -58.3 -52.6
NL
argenx SE
XBRU:ARGX
37.6B EUR 17.8 -344.7 -163.8 -106.7
P/S Multiple
Revenue Growth P/S to Growth
US
PureTech Health PLC
NASDAQ:PRTC
Average P/S: 3 485 819.7
934.6
62%
15.1
FR
Pharnext SCA
OTC:PNEXF
38 341 173.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
6%
1
US
Amgen Inc
NASDAQ:AMGN
4.3
8%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
4
3%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
1 837.4
N/A N/A
AU
CSL Ltd
ASX:CSL
5.9
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
7%
0.8
US
S
Seagen Inc
F:SGT
17.7
30%
0.6
NL
argenx SE
XBRU:ARGX
17.8
47%
0.4
P/E Multiple
Earnings Growth PEG
US
PureTech Health PLC
NASDAQ:PRTC
Average P/E: 208.4
Negative Multiple: -5.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -182 229.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
62.4
72%
0.9
US
Amgen Inc
NASDAQ:AMGN
33.3
20%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
896.2
21%
42.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -219.3
14%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -468.9 N/A N/A
AU
CSL Ltd
ASX:CSL
32.9
18%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
13%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.3 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -344.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
PureTech Health PLC
NASDAQ:PRTC
Average EV/EBITDA: 65.9
362.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -221 285.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
9%
1.7
US
Amgen Inc
NASDAQ:AMGN
16
18%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
5%
2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.6
13%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -510.6 N/A N/A
AU
CSL Ltd
ASX:CSL
20.3
12%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.7
11%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.3 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -163.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
PureTech Health PLC
NASDAQ:PRTC
Average EV/EBIT: 68.9
352.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 760 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.9
24%
1
US
Amgen Inc
NASDAQ:AMGN
30.3
24%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
10%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.7
13%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -497 N/A N/A
AU
CSL Ltd
ASX:CSL
25.3
16%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
12%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -52.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -106.7 N/A N/A